Suppr超能文献

维拉帕米诱发的心脏淀粉样变性中的左心室收缩功能障碍。

Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis.

作者信息

Pollak A, Falk R H

机构信息

Department of Medicine, Boston City Hospital 02118.

出版信息

Chest. 1993 Aug;104(2):618-20. doi: 10.1378/chest.104.2.618.

Abstract

Cardiac amyloidosis produces a restrictive cardiomyopathy with impaired diastolic function. We report a case in which low-dose verapamil resulted in marked worsening of congestive heart failure, as a result of a profound negative inotropic effect. Withdrawal of verapamil therapy demonstrated a return of systolic function to normal with improvement in heart failure. We postulate that patients with cardiac amyloidosis may be exceptionally sensitive to the negative inotropic effects of calcium-channel blockers either because of abnormal binding to amyloid fibrils or because their usual vasodilator effects are blunted.

摘要

心脏淀粉样变性会导致舒张功能受损的限制性心肌病。我们报告了一例低剂量维拉帕米导致充血性心力衰竭显著恶化的病例,这是由于其明显的负性肌力作用。停用维拉帕米治疗后,收缩功能恢复正常,心力衰竭症状改善。我们推测,心脏淀粉样变性患者可能对钙通道阻滞剂的负性肌力作用异常敏感,原因可能是与淀粉样纤维异常结合,或者是其通常的血管舒张作用减弱。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验